Conference abstractPublished 24 Jan 2020
Delivery method of the silencers RNA by PBCA nanoparticles for the treatment of multiform glioblastoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Glioblastoma multiform (GBM) has been reported as the most severe and the deadliest brain cancer, with a prognosis of only 14 months. Treatment is executed by the extraction of the tumor, followed by a radiation therapy and chemotherapy. Nowadays, brain therapy has found great obstacles to become effective due to factors such as the drug resistance and the difficulty to cross the blood-brain barrier. One of the great promises for the diagnosis, treatment and precaution of several diseases has been the use of nanoparticles (NPs). Among the different types of NPs, the PBCA nanoparticles have been gaining space in medicine because of its unique properties and its multiples employability. PBCA nanoparticles also have the ability to cross the blood-brain barrier (BBB). Another great promise in the treatment of diseases is the use of interfering RNA technique by presenting a specific and unique gene silencing capacity through molecules denominated in this project a silencers RNA. Several researches have been conducted focusing on several categories of cancers, which have been employed different NPs, as well as the use of diverse silencers RNA. The aim of this project is to create a delivery method of RNA silencers by nanoparticles for the treatment of GBM. So, to achieve it, different mechanisms will be used in the topography of PBCA-NPs to make them specific tumor tissue, besides using the silencers RNA focused on genes that brings resistance to most important drug and also genes responsible for the maintaining of tumor cells in different lines cell: U87/U118-GM and patients cells. Therefore, the main purpose of this project is to create an alternative method of treating one of the deadliest cancers from two scientific pillars of major biotechnological fields of modern medicine: nanoparticles and interfering RNA.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacology and Medicinal Chemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Cyro von Zuben V Negrao”
